Anthony C. Arvanites

1.9k total citations · 1 hit paper
18 papers, 1.4k citations indexed

About

Anthony C. Arvanites is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, Anthony C. Arvanites has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Neurology. Recurrent topics in Anthony C. Arvanites's work include Neurogenetic and Muscular Disorders Research (5 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Anthony C. Arvanites is often cited by papers focused on Neurogenetic and Muscular Disorders Research (5 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Anthony C. Arvanites collaborates with scholars based in United States, Austria and Canada. Anthony C. Arvanites's co-authors include Lee L. Rubin, Kelvin Lam, David Kokel, Randall T. Peterson, Sumin Jang, Stephen J. Haggarty, Alexander F. Schier, David A. Prober, Jason Rihel and Steven Zimmerman and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Anthony C. Arvanites

18 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation

2010 572 citations Jason Rihel, David A. Prober et al. Science profile →

Peers

Countries citing papers authored by Anthony C. Arvanites

Since Specialization

Citations

This map shows the geographic impact of Anthony C. Arvanites's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony C. Arvanites with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony C. Arvanites more than expected).

Fields of papers citing papers by Anthony C. Arvanites

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony C. Arvanites. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony C. Arvanites. The network helps show where Anthony C. Arvanites may publish in the future.

Co-authorship network of co-authors of Anthony C. Arvanites

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony C. Arvanites. A scholar is included among the top collaborators of Anthony C. Arvanites based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony C. Arvanites. Anthony C. Arvanites is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer 2022 ·Science Translational Medicine ·Shane J. F. Cronin, Shuan Rao, Miguel Á. Tejada, Bruna Lenfers Turnes, (unknown), Takao Omura, Christian Brenneis, (unknown), Lee Barrett, Alban Latrémolière, Nick Andrews, Keith M. Channon, Alexandra Latini, Anthony C. Arvanites, Lance S. Davidow, Michael Costigan, Lee L. Rubin, Josef Penninger, Clifford J. Woolf	21
2	Synthetic modified Fezf2 mRNA (modRNA) with concurrent small molecule SIRT1 inhibition enhances refinement of cortical subcerebral/corticospinal neuron identity from mouse embryonic stem cells 2021 ·PLoS ONE ·Cameron Sadegh, Wataru Ebina, Anthony C. Arvanites, Lance S. Davidow, Lee L. Rubin, Jeffrey D. Macklis	2
3	Nucleophilic aromatic substitution in chlorinated aromatic systems with a glutathione thiolate model 2016 ·Journal of Physical Organic Chemistry ·(unknown), Anthony C. Arvanites	1
4	Reversal of β cell de-differentiation by a small molecule inhibitor of the TGFβ pathway 2014 ·eLife ·Barak Blum, (unknown), Ornella Barrandon, René Maehr, Anthony C. Arvanites, Lance S. Davidow, Jeffrey C. Davis, Quinn P. Peterson, Lee L. Rubin, Douglas A. Melton	109
5	Repurposing cAMP-Modulating Medications to Promote β-Cell Replication 2014 ·Molecular Endocrinology ·(unknown), Yen Low, N. Armstrong, (unknown), Sara A. Sun, Anthony C. Arvanites, Jennifer Hollister‐Lock, Nigam H. Shah, Gordon C. Weir, Justin P. Annes	28
6	A Small Molecule Screen in Stem-Cell-Derived Motor Neurons Identifies a Kinase Inhibitor as a Candidate Therapeutic for ALS 2013 ·Cell stem cell ·Yin Yang, Shailesh Gupta, Kevin J. Kim, Berit Powers, (unknown), Brian J. Wainger, (unknown), Kathryn A. Rosowski, (unknown), Courtney Ackeifi, Anthony C. Arvanites, Lance S. Davidow, Clifford J. Woolf, Lee L. Rubin	228
7	Glucocorticoid Compounds Modify Smoothened Localization and Hedgehog Pathway Activity 2012 ·Chemistry & Biology ·Yu Wang, Lance S. Davidow, Anthony C. Arvanites, Joel Blanchard, Kelvin Lam, Ke Xu, (unknown), (unknown), Jessica M.Y. Ng, Tom Curran, Lee L. Rubin, Andrew P. McMahon	58
8	Selective Identification of Hedgehog Pathway Antagonists By Direct Analysis of Smoothened Ciliary Translocation 2012 ·ACS Chemical Biology ·Yu Wang, Anthony C. Arvanites, Lance S. Davidow, Joel Blanchard, Kelvin Lam, (unknown), Shannon Coy, Lee L. Rubin, Andrew P. McMahon	40
9	Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication 2012 ·Proceedings of the National Academy of Sciences ·Justin P. Annes, (unknown), Kelvin Lam, Peter J. Carolan, (unknown), Jennifer Hollister‐Lock, Anthony C. Arvanites, Lee L. Rubin, Gordon C. Weir, Douglas A. Melton	116
10	A screen for regulators of survival of motor neuron protein levels 2011 ·Nature Chemical Biology ·Nina R. Makhortova, (unknown), (unknown), (unknown), Wen‐Ning Zhao, Patrick W. Heiser, Anthony C. Arvanites, Lance S. Davidow, (unknown), Judith A. Steen, Kelvin Lam, (unknown), Lee L. Rubin	61
11	Cyclohexane 1,3-diones and their inhibition of mutant SOD1-dependent protein aggregation and toxicity in PC12 cells 2011 ·Bioorganic & Medicinal Chemistry ·Wei Zhang, (unknown), Anthony C. Arvanites, Richard I. Morimoto, Robert J. Ferrante, Donald R. Kirsch, Richard B. Silverman	26
12	Pyrimidine-2,4,6-trione Derivatives and Their Inhibition of Mutant SOD1-Dependent Protein Aggregation. Toward a Treatment for Amyotrophic Lateral Sclerosis 2011 ·Journal of Medicinal Chemistry ·Guoyao Xia, (unknown), Jin-Ho Kim, Anthony C. Arvanites, Richard I. Morimoto, Robert J. Ferrante, Donald R. Kirsch, Richard B. Silverman	43
13	Virtual drug discovery: beyond computational chemistry? 2010 ·Expert Opinion on Drug Discovery ·François Gilardoni, Anthony C. Arvanites	1
14	Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation breakdown → 2010 ·Science ·Jason Rihel, David A. Prober, Anthony C. Arvanites, Kelvin Lam, Steven Zimmerman, Sumin Jang, Stephen J. Haggarty, David Kokel, Lee L. Rubin, Randall T. Peterson, Alexander F. Schier	572
15	Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosis 2010 ·Amyotrophic Lateral Sclerosis ·(unknown), Anthony C. Arvanites, Jinho Kim, Robert J. Ferrante, Richard B. Silverman, Richard I. Morimoto, Donald R. Kirsch	35
16	Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis 2010 ·Bioorganic & Medicinal Chemistry ·Tian Chen, (unknown), Anthony C. Arvanites, Hantamalala Ralay Ranaivo, Richard I. Morimoto, Robert J. Ferrante, D. Martin Watterson, Donald R. Kirsch, Richard B. Silverman	21
17	Identification and Characterization of Inhibitors of Bacterial Enoyl-Acyl Carrier Protein Reductase 2004 ·Antimicrobial Agents and Chemotherapy ·Losee L. Ling, Jun Xian, Syed Muhammad Adnan Ali, Bolin Geng, Jun Fan, Debra M. Mills, Anthony C. Arvanites, Hernán A. Orgueira, Mark A. Ashwell, Gilles Carmel, Yibin Xiang, Donald T. Moir	58
18	Modeling of the mechanism of nucleophilic aromatic substitution of fungicide chlorothalonil by glutathione 2001 ·Journal of Molecular Modeling ·Anthony C. Arvanites, (unknown)	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact